{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:10:32Z","timestamp":1779426632914,"version":"3.53.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7242207"],"award-info":[{"award-number":["7242207"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmc.2026.118635","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T20:24:53Z","timestamp":1774815893000},"page":"118635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of O-benzoyl amidoxime derivatives as novel TLR2\/1 agonists with potent anti-radiation activity in mice"],"prefix":"10.1016","volume":"137","author":[{"given":"Hanyin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118635_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118635_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1667\/RADE-23-00196.1","article-title":"Gastrointestinal acute radiation syndrome: mechanisms, models, markers, and medical countermeasures","volume":"201","author":"Winters","year":"2024","journal-title":"Radiat Res"},{"key":"10.1016\/j.bmc.2026.118635_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094055","article-title":"Identification of potential prophylactic medical countermeasures against acute radiation syndrome (ARS)","volume":"26","author":"Liermann-Wooldrik","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118635_bb0020","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1080\/13543776.2016.1231805","article-title":"Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents","volume":"26","author":"Singh","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2026.118635_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dot.2022.58.3.3367994","article-title":"An update on romiplostim for treatment of acute radiation syndrome","volume":"58","author":"Singh","year":"2022","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.bmc.2026.118635_bb0030","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1038\/s41598-024-56135-w","article-title":"Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol","volume":"14","author":"Singh","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149661","article-title":"Sequential administration of delta-tocotrienol ameliorates radiation-induced myelosuppression in mice and non-human primates through inducing G-CSF production","volume":"704","author":"Wang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118635_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1667\/RADE-22-00208.1","article-title":"Further characterization of multi-organ DEARE and protection by 16,16 dimethyl prostaglandin e2 in a mouse model of the hematopoietic acute radiation syndrome","volume":"199","author":"Wu","year":"2023","journal-title":"Radiat Res"},{"key":"10.1016\/j.bmc.2026.118635_bb0045","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41598-022-07426-7","article-title":"Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821)","volume":"12","author":"Kumar","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09553002.2019.1605465","article-title":"Romiplostim (Nplate((R))) as an effective radiation countermeasure to improve survival and platelet recovery in mice","volume":"96","author":"Bunin","year":"2020","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.bmc.2026.118635_bb0055","doi-asserted-by":"crossref","first-page":"31378","DOI":"10.1038\/s41598-025-17099-7","article-title":"Characterization of rhesus macaque model for cobalt-60 gamma-radiation source without use of blood product","volume":"15","author":"Wise","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0060","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1038\/s41598-021-85044-5","article-title":"Integrative network analyses of transcriptomics data reveal potential drug targets for acute radiation syndrome","volume":"11","author":"Moore","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/09553002.2021.1969054","article-title":"Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond","volume":"97","author":"Singh","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.bmc.2026.118635_bb0070","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1038\/s41598-023-49499-y","article-title":"Human cell-expressed tag-free rhMFG-E8 as an effective radiation mitigator","volume":"13","author":"Chaung","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bmc.2026.118635_bb0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/acs.bioconjchem.7b00808","article-title":"Toll-like receptor agonist conjugation: a chemical perspective","volume":"29","author":"Ignacio","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0085","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1021\/acs.jmedchem.2c01655","article-title":"Small-molecule modulators targeting toll-like receptors for potential anticancer therapeutics","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0090","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1021\/acs.jcim.3c00419","article-title":"Recent advances in studying toll-like receptors with the use of computational methods","volume":"63","author":"Bzowka","year":"2023","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118635_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1154986","article-title":"An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models","volume":"320","author":"Burdelya","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bmc.2026.118635_bb0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41420-021-00642-6","article-title":"Signaling through TLR5 mitigates lethal radiation damage by neutrophil-dependent release of MMP-9","volume":"7","author":"Brackett","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bmc.2026.118635_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1667\/RADE-22-00200.1","article-title":"TLR4 agonist MPLA ameliorates heavy-ion radiation damage via regulating DNA damage repair and apoptosis","volume":"200","author":"Liu","year":"2023","journal-title":"Radiat Res"},{"key":"10.1016\/j.bmc.2026.118635_bb0110","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1111\/jcmm.14978","article-title":"Monophosphoryl lipid a alleviated radiation-induced testicular injury through TLR4-dependent exosomes","volume":"24","author":"Liu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2026.118635_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122178120","article-title":"The TLR2\/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates","volume":"120","author":"Brickey","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118635_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115303","article-title":"FSL-1 pre-administration protects radiation-induced hematopoietic organs through the modulation of the TLR signaling pathway","volume":"26","author":"Dronamraju","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118635_bb0125","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1111\/jcmm.16252","article-title":"Novel chimeric TLR2\/NOD2 agonist CL429 exhibited significant radioprotective effects in mice","volume":"25","author":"Cheng","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2026.118635_bb0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000480472","article-title":"Zymosan-a protects the hematopoietic system from radiation-induced damage by targeting TLR2 signaling pathway","volume":"43","author":"Du","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.bmc.2026.118635_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17729-9","article-title":"The toll-like receptor 2\/6 agonist, FSL-1 lipopeptide, therapeutically mitigates acute radiation syndrome","volume":"7","author":"Kurkjian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0140","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1038\/ncomms4492","article-title":"Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome","volume":"5","author":"Takemura","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2026.118635_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12967-022-03804-x","article-title":"Monophosphoryl lipid a ameliorates radiation-induced lung injury by promoting the polarization of macrophages to the m1 phenotype","volume":"20","author":"Guo","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.bmc.2026.118635_bb0150","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118635_bb0155","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1039\/C8CC06618C","article-title":"Structure-based discovery of a specific TLR1-TLR2 small molecule agonist from the ZINC drug library database","volume":"54","author":"Chen","year":"2018","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.bmc.2026.118635_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2019.02.067","article-title":"Synthesis of urea analogues bearing N-alkyl-N'-(thiophen-2-yl) scaffold and evaluation of their innate immune response to toll-like receptors","volume":"169","author":"Chen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0165","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1021\/acs.jmedchem.0c02266","article-title":"Design, synthesis, and structure-activity relationship of N-aryl-N'-(thiophen-2-yl)thiourea derivatives as novel and specific human TLR1\/2 agonists for potential cancer immunotherapy","volume":"64","author":"Chen","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0170","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1021\/acs.jmedchem.3c01984","article-title":"Design and synthesis of 3-(2H-Chromen-3-yl)-5-aryl-1,2,4-oxadiazole derivatives as novel toll-like receptor 2\/1 agonists that inhibit lung cancer in vitro and in vivo","volume":"67","author":"Wang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0175","doi-asserted-by":"crossref","first-page":"1802042","DOI":"10.1002\/advs.201802042","article-title":"TLR1\/2 specific small-molecule agonist suppresses leukemia cancer cell growth by stimulating cytotoxic t lymphocytes","volume":"6","author":"Cen","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bmc.2026.118635_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acsmedchemlett.8b00540","article-title":"Identification of human toll-like receptor 2-agonistic activity in Dihydropyridine-quinolone carboxamides","volume":"10","author":"Hu","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118635_bb0185","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.jmedchem.8b01583","article-title":"Structural basis of TLR2\/TLR1 activation by the synthetic agonist diprovocim","volume":"62","author":"Su","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0190","first-page":"E8698","article-title":"Adjuvant effect of the novel TLR1\/TLR2 agonist diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2026.118635_bb0195","doi-asserted-by":"crossref","first-page":"17015","DOI":"10.1021\/acs.joc.5c02114","article-title":"Development of two synthetic routes to a benzofuran intermediate for fruquintinib","volume":"90","author":"Han","year":"2025","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0200","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/ol403645y","article-title":"Practical synthesis of n-substituted cyanamides via tiemann rearrangement of amidoximes","volume":"16","author":"Lin","year":"2014","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2026.118635_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2023.154590","article-title":"A new method to synthesize 1,2,4-oxadiazoles by using DMTMM as condensing agent","volume":"124","author":"Wang","year":"2023","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2026.118635_bb0210","doi-asserted-by":"crossref","first-page":"1049340","DOI":"10.3389\/fimmu.2022.1049340","article-title":"Toll-like receptor-targeted anti-tumor therapies: advances and challenges","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2026.118635_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104299","article-title":"Protective effects of polysaccharides from sipunculus nudus on beagle dogs exposed to gamma-radiation","volume":"9","author":"Cui","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118635_bb0220","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.3390\/ijms12128913","article-title":"Production and radioprotective effects of pyrroloquinoline quinone","volume":"12","author":"Xiong","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118635_bb0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/med.21386","article-title":"Radioprotective agents: strategies and translational advances","volume":"36","author":"Kamran","year":"2016","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2026.118635_bb0230","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/acs.molpharmaceut.3c00600","article-title":"Advances of amifostine in radiation protection: administration and delivery","volume":"20","author":"Ji","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2026.118635_bb0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s42003-021-01978-6","article-title":"A deimmunized and pharmacologically optimized toll-like receptor 5 agonist for therapeutic applications","volume":"4","author":"Mett","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmc.2026.118635_bb0240","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.12953","article-title":"Radioprotective countermeasures for radiation injury (review)","volume":"27","author":"Liu","year":"2023","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2026.118635_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s10020-025-01198-2","article-title":"Diprovocim protects against the radiation-induced damage via the TLR2 signaling pathway","volume":"31","author":"Fang","year":"2025","journal-title":"Mol Med"},{"key":"10.1016\/j.bmc.2026.118635_bb0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbrc.2018.11.080","article-title":"TLR5 binding and activation by KMRC011, a flagellin-derived radiation countermeasure","volume":"508","author":"Song","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118635_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116239","article-title":"Design, synthesis, biological evaluation and in silico studies of novel quinoline derivatives as potential radioprotective molecules targeting the TLR2 and p53 pathways","volume":"268","author":"Cui","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118635_bb0260","doi-asserted-by":"crossref","first-page":"2458189","DOI":"10.1080\/19490976.2025.2458189","article-title":"MIIST305 mitigates gastrointestinal acute radiation syndrome injury and ameliorates radiation-induced gut microbiome dysbiosis","volume":"17","author":"Mitra","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bmc.2026.118635_bb0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.112.196071","article-title":"Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure","volume":"343","author":"Krivokrysenko","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2026.118635_bb0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drudis.2020.10.003","article-title":"Entolimod as a radiation countermeasure for acute radiation syndrome","volume":"26","author":"Singh","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118635_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135388","article-title":"The toll-like receptor 5 agonist entolimod mitigates lethal acute radiation syndrome in non-human primates","volume":"10","author":"Krivokrysenko","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118635_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/14737159.2016.1121102","article-title":"Use of biomarkers for assessing radiation injury and efficacy of countermeasures","volume":"16","author":"Singh","year":"2016","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962600091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:00:21Z","timestamp":1779426021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962600091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S096808962600091X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118635","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of O-benzoyl amidoxime derivatives as novel TLR2\/1 agonists with potent anti-radiation activity in mice","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118635"}}